4//SEC Filing
MCCANN JOE A. 4
Accession 0001104659-22-123356
CIK 0001811764other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 7:56 PM ET
Size
5.1 KB
Accession
0001104659-22-123356
Insider Transaction Report
Form 4
MCCANN JOE A.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-11-29$6.64/sh+2,160$14,342→ 3,616,313 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.639 to $6.640, inclusive. The Reporting Person undertakes to provide to POINT Biopharma Global Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001868644
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 7:56 PM ET
- Size
- 5.1 KB